Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Apraxia of Speech: later-stage trial registry
5 of 6 indexed Apraxia of Speech trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 5 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Apraxia of Speech: 6 US clinical trials tracked, 5 recruiting.
Apraxia of Speech is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is University of Central Florida, running 2 of these trials.
Enrollment posture brief
Registry condition apraxia-of-speech
OPEN 5 | RECR 83% | LATE 1 | EARLY 0 | RANK #2866 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Alcoholic Hepatitis (83% recruiting · 6 trials)
Apraxia of Speech lists 5 open slots (83% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Apraxia of Speech on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Apraxia of Speech is recruiting above its size-band peers.
5 of 6 indexed trials (83.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Apraxia of Speech research.
University of Central Florida accounts for 2 of 6 trials (33.3%). 4 distinct sponsors appear on at least one study for this condition label.
-
Most Apraxia of Speech trials plan to enrol fewer than 100 people.
Median target enrolment is 47 among the 6 trials that report a genuine target (sentinel values excluded). 6 of those (100%) plan for fewer than 100 participants.
-
Apraxia of Speech research is mostly interventional.
5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Measuring Aided Language Development
University of Central Florida
NCT06512168
Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech
Mayo Clinic
NCT01818661
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
Mayo Clinic
NCT03313011
Using tDCS in Speech-based Stroke Rehabilitation
NYU Langone Health
NCT03452202
Motor Imagery for Treatment Enhancement and Efficacy in Persons With Apraxia of Speech
University of Central Florida
NCT06467136
Treating Primary Progressive Aphasia and Apraxia of Speech Using Non-invasive Brain Stimulation
The University of Texas at Dallas
NCT05368350
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Apraxia of Speech records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Apraxia of Speech trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Apraxia of Speech page
6 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Apraxia of Speech trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Central Florida sponsors the most Apraxia of Speech trials on record, review their full trial history before evaluating a specific study. See University of Central Florida's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Apraxia of Speech condition card totals 6 registered trials; most-linked intervention high-definition transcranial direct current stimulation (HD-tDCS); top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.